Hepatitis A, B, C and HIV infections among Finnish female prisoners - Young females a risk group

Journal of Infection

Volumn 62, Issue 1, 2011, Pages 59-66

  Viitanen, P ^a,b   Vartiainen, H ^a,c,d   Aarnio, J ^a,b   von Gruenewaldt, V ^a   Hakamaki S ^a,b   Lintonen, T ^b,e   Mattila, A K ^b,f   Wuolijoki, T ^a,b   Joukamaa, M ^b,f  

^a Prison Health Services   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e Poliisiammattikorkeakoulu   (Finland)

^f TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Female; Hepatitis A; Hepatitis B; Hepatitis C; HIV; Intravenous drug use; Prisoner

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FINLAND; HEPATITIS A; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRISONER; RACE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; SYRINGE; TATTOO; UNSAFE SEX;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; FEMALE; FINLAND; HEPACIVIRUS; HEPATITIS A VIRUS, HUMAN; HEPATITIS ANTIBODIES; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HIV; HIV ANTIBODIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; PREVALENCE; PRISONERS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 78751617554     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.10.011     Document Type: Article

References (40)

1. The Criminal Sanctions Agency. Making Women Visible. Helsinki; 2008. 3/2008 [in Finnish].
2. Women's health in prison, Correcting gender inequity in prison health 2009, World Health Organization, Regional Office for Europe, EUR/09/5086974.
3. Holloway K., Bennett T. Gender differences in drug misuse and related problem behaviors among arrestees in the UK. Subst Use Misuse 2007, 42(6):899-921.
4. European Monitoring Centre for Drugs and Drug Addiction. Annual report 2004: the state of the drugs problem in the European Union and Norway; 2004.
5. Babudieri S., Longo B., Sarmati L., Starnini G., Dori L., Suligoi B., et al. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol 2005, 76(3):311-317.
6. Weild A.R., Gill O.N., Bennett D., Livingstone S.J., Parry J.V., Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Commun Dis Public Health 2000, 3(2):121-126.
7. Allwright S., Bradley F., Long J., Barry J., Thornton L., Parry J.V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. Br Med J 2000, 321(7253):78-82.
8. Hutchinson S.J., Roy K.M., Wadd S., Bird S.M., Taylor A., Anderson E., et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scott Med J 2006, 51(2):8-15.
9. Santana Rodriguez O.E., Male Gil M.L., Hernandez Santana J.F., Liminana Canal J.M., Martin Sanchez A.M. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 1998, 14(6):555-561.
10. Karvonen A. Virus hepatitis. Gastroenterology and hepatology 2007, 700-709. Kustannus Oy Duodecim, Helsinki, [in Finnish]. K. Höckerstedt, M. Färkkilä, E. Kivilaakso, P. Pikkarainen (Eds.).
11. Vescio M.F., Longo B., Babudieri S., Starnini G., Carbonara S., Rezza G., et al. Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health 2008, 62(4):305-313.
12. Crofts N., Stewart T., Hearne P., Ping X.Y., Breschkin A.M., Locarnini S.A. Spread of bloodborne viruses among Australian prison entrants. Br Med J 1995, 310:285-288.
13. Hellard M.E., Hocking J.S., Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004, 132(3):409-415.
14. Long J, Allwright S, Barry J, Reaper-Reynolds S, Thornton L, Bradley F. Hepatitis B. Hepatitis C and HIV in Irish Prisoners, Part II: Prevalence and Risk in Committal Prisoners 1999; 20003
15. Ford P.M., White C., Kaufmann H., MacTavish J., Pearson M., Ford S., et al. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. Can Med Assoc J 1995, 153(11):1605-1609.
16. Christensen P.B., Krarup H.B., Niesters H.G., Norder H., Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur J Epidemiol 2000, 16(11):1043-1049.
17. Fox R.K., Currie S.L., Evans J., Wright T.L., Tobler L., Phelps B., et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005, 41(2):177-186.
18. Miller E.R., Bi P., Ryan P. The prevalence of HCV antibody in South Australian prisoners. J Infect 2006, 53(2):125-130.
19. Van Beek I., Dwyer R., Dore G.J., Luo K., Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br Med J 1998, 317:433-437.
20. Stark K., Bienzle U., Vonk R., Guggenmoos-Holzmann I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol 1997, 26(6):1359-1366.
21. The Criminal Sanctions Agency Statistics, [accessed 26 September 2009]. http://www.rikosseuraamus.fi/16928.htm.
22. Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I), Clinician version, administration booklet 1997, American Psychiatric Publishing Inc., New York. M. First, J. Williams, R. Spitzer (Eds.).
23. World Health Organization. Hepatitis C - global prevalence (update).Wkly Epidemiol Rec;74(49):425-427.
24. Muehlberger M., Schwarzer R., Lettmeier B., Sroczynski G., Zeuzem S., Siebert U. HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality. BMC Public Health 2009, 9(34).
25. Lauer G.M., Walker B.D. Hepatitis C virus infection. N Engl J Med 2001, 345(1):41-52.
26. National Public Health Institute The statistical database of the infectious diseases Register, [accessed 29 Sep 2009]. http://www3.ktl.fi/stat.
27. Solomon L., Flynn C., Muck K., Vertefeuille J. Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities. J Urban Health 2004, 81(1):25-37.
28. Ruiz J.D., Molitor F., Sun R.K., Mikanda J., Facer M., Colford J.M., et al. Prevalence and correlates of hepatitis C virus infection among inmates entering the California correctional system. West J Med 1999, 170(3):156-160.
29. Malliori M., Sypsa V., Psichogiou M., Touloumi G., Skoutelis A., Tassopoulos N., et al. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction 1998, 93(2):243-251.
30. Infections in Finland 2007 2008, National Public Health Institute, Helsinki, KTL B10/2008 [in Finnish].
31. Lintonen T, Vartiainen H, Aarnio J, von Gruenewaldt V, Hakamäki S, Viitanen P, et al. Drug abuse among prisoners - by any definition, it's a big problem. Subst Use Misuse, in press.
32. Mallat A., Hezode C., Lotersztajn S. Environmental factors as disease accelerators during chronic hepatitis C. J Hepatol 2008, 48(4):657-665.
33. Pessione F., Ramond M.J., Njapoum C., Duchatelle V., Degott C., Erlinger S., et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology 2001, 34(1):121-125.
34. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36(5 Suppl. 1):S35-S46.
35. Freeman A.J., Dore G.J., Law M.G., Thorpe M., Von Overbeck J., Lloyd A.R., et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 2001, 34(4 Pt 1):809-816.
36. Salminen M. Finland 2008 UNGASS HIV/Aids country report; 2008. KTL B4/2008.
37. Leino T. Assessment of the hepatitis B vaccination program. Helsinki; 2006. KTL B9/2006 [in Finnish].
38. Allwright S, Barry J, Bradley F, Long J, Thornton L. Hepatitis B, Hepatitis C and HIV in Irish Prisoners: Prevalence and Risk; 1999.
39. Plugge E.H., Yudkin P.L., Douglas N. Predictors of hepatitis B vaccination in women prisoners in two prisons in England. J Public Health 2007, 29(4):429-433.
40. Andersen H.S. Mental health in prison populations. A review - with special emphasis on a study of Danish prisoners on remand. Acta Psychiatr Scand 2004, 110(Suppl. 424):5-59.